TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,563,000 | +79.0% | 886,281 | -1.1% | 5.66% | +58.3% |
| Q2 2021 | $8,694,000 | -38.8% | 896,281 | -32.3% | 3.57% | -40.3% |
| Q1 2021 | $14,211,000 | -34.6% | 1,323,181 | -10.5% | 5.99% | -23.0% |
| Q4 2020 | $21,744,000 | -1.8% | 1,478,181 | -5.1% | 7.78% | -17.1% |
| Q3 2020 | $22,142,000 | +84.5% | 1,558,181 | +5.1% | 9.38% | +75.2% |
| Q2 2020 | $11,999,000 | +63.4% | 1,483,181 | -18.4% | 5.35% | +20.1% |
| Q1 2020 | $7,345,000 | – | 1,818,181 | – | 4.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|